Endotyping-informed therapy guided by adenosine stress cardiovascular MRI revised diagnoses in over half of patients with chest pain and unobstructed coronary arteries and significantly improved angina and quality of life at 12 months. In this prospective, multicenter, randomized controlled trial of 250 patients (mean age 63.3 years; 50.4% female) in Scotland, stress MRI—used to measure myocardial blood flow and detect coronary microvascular dysfunction—reclassified the initial angiogram-based diagnosis in 53.0% of participants. The intervention also met the randomized trial’s primary outcome: patients receiving MRI-guided management had markedly better Seattle Angina Questionnaire summary scores at 12 months than controls (70.9 ± 23.6 vs. 52.1 ± 24.1; adjusted mean difference 20.9). Quality of life improved as well, reflected by a significant benefit in the EQ-5D-5L score (adjusted mean difference 0.09). These results demonstrate that functional endotyping meaningfully clarifies diagnosis and enhances patient-centered outcomes in those with chest pain but no obstructive coronary disease, and provide new evidence in support of a primary role for functional imaging coupled with either invasive angiography or coronary computed tomography angiography. Source: https://www.nature.com/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.